Patritumab

(Synonyms: AMG 888; U3-1287)
2 Cited Publications
Kundenbewertung

Based on 2 publication(s) in Google Scholar

Patritumab (AMG 888; U3-1287) is a neutralizing antibody targeting HER3 (ErbB3) that binds to the extracellular domain and induces HER3 internalization. Patritumab prevents heregulin binding, downregulates cell surface HER3, and blocks ligand-induced HER3 phosphorylation and downstream PI3K/AKT signaling. Patritumab in combination with dual HER2 blockade enhances apoptosis and growth inhibition in HER2-overexpressing breast cancer cells, and enhances antitumor effects in xenograft tumors. Patritumab can be used for research on breast cancer.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

  • Reinheit : 99.28%
  • CAS. Nr.: 1262787-83-6
  • Molecular Weight:146.86 kDa
  • Speicherung:
    Shipping with dry ice

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biologische Aktivität
  • Chemical Information
  • Protokoll
  • Reinheit & Dokumentation
  • Verweise
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

Angebot einholen Auf Lager

Other size
Angebot einholen
Please select quantity
Amount: USD 0.00